Álvarez-Luquín D, Arce-Sillas A, Leyva-Hernández J, Sevilla-Reyes E, Boll M, Montes-Moratilla E, Vivas-Almazán V, Pérez-Correa C, Rodríguez-Ortiz U, Espinosa-Cárdenas R, Fragoso G, Sciuto E, Adalid-Peralta L (2019) Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs other regulatory populations are also involve. J Neuroinflamm 16(212):1–11

Google Scholar 

Arce-Sillas A, Álvarez-Luquín DD, Cárdenas G, Casanova-Hernández D, Fragoso G, Hernández M, Proaño Narváez JV, García-Vázquez F, Fleury A, Sciutto E, Adalid-Peralta L (2016) Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis. Clin Exp Immunol 183(2):271–279. https://doi.org/10.1111/cei.12709

Article  CAS  PubMed  Google Scholar 

Arce-Sillas A, Sevilla-Reyes E, Álvarez-Luquín DD, Guevara-Salinas A, Boll MC, Pérez-Correa CA, Vivas-Almazan AV, Rodríguez-Ortiz U, Castellanos Barba C, Hernandez M, Fragoso G, Sciutto E, Cárdenas G, Adalid-Peralta LV (2019) Expression of dopamine receptors in immune regulatory cells. NeuroImmunoModulation 26(3):159–165. https://doi.org/10.1159/000501187

Article  CAS  PubMed  Google Scholar 

Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27(1):27–42. https://doi.org/10.1111/ene.14108

Article  CAS  PubMed  Google Scholar 

Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E (2007) The role of CD8 CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand. Proc Natl Acad Sci 104:17459–17464

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biragyn A, Aliseychik M, Rogaev E (2017) Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol 39(3):283–294. https://doi.org/10.1007/s00281-016-0615-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C (2010) CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32(1):129–140. https://doi.org/10.1016/j.immuni.2009.11.009

Article  CAS  PubMed  Google Scholar 

Chen Y, Qi B, Xu W, Ma B, Li L, Chen Q, Qian W, Liu X, Qu H (2015) Clinical correlation of peripheral CD4+-cell sub-sets, their imbalance and Parkinson’s disease. Mol Med Rep 12(4):6105–6111. https://doi.org/10.3892/mmr.2015.4136

Article  CAS  PubMed  Google Scholar 

Coley JS, Calderon TM, Gaskill PJ, Eugenin EA, Berman JW (2015) Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis. PLoS ONE. https://doi.org/10.1371/journal.pone.0117450

Article  PubMed  PubMed Central  Google Scholar 

Cosentino M, Kustrimovic N, Ferrari M, Rasini E, Marino F (2018) cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms. Immunology 153(3):337–341. https://doi.org/10.1111/imm.12843

Article  CAS  PubMed  Google Scholar 

Diagnóstico y tratamiento de la Enfermedad de Parkinson inicial y avanzada en el tercer nivel de atención (2010) México, Secretaría de Salud. www.cenetec.salud.gob.mx

Filippi M, Elisabetta S, Piramide N, Agosta F (2018) Functional MRI in idiopathic Parkinson’s disease. Int Rev Neurobiol 141:439–467. https://doi.org/10.1016/bs.irn.2018.08.005

Article  CAS  PubMed  Google Scholar 

Garfias S, Tamaya Domínguez B, Toledo Rojas A, Arroyo M, Rodríguez U, Boll C, Sosa AL, Sciutto E, Adalid-Peralta L, Martinez López Y, Fragoso G, Fleury A (2022) Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson’s diseases. Neurología (engl Edn) 37(2):110–121. https://doi.org/10.1016/j.nrleng.2018.10.022

Article  Google Scholar 

Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M (2019) Canadian guideline for Parkinson disease. CMAJ 191(36):989–1004

Article  Google Scholar 

Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC, Weishaupt JH, Danzer KM (2014) Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients. Acta Neuropathol 128(5):651–663. https://doi.org/10.1007/s00401-014-1345-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179–187. https://doi.org/10.1016/j.expneurol.2017.11.010

Article  CAS  PubMed  Google Scholar 

Hu D, Weiner HL, Ritz J (2013) Identification of cytolytic CD161-CD56+ regulatory CD8 T cells in human peripheral blood. PLoS ONE. https://doi.org/10.1371/journal.pone.0059545

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP (2017) Treg cells protect dopaminergic neurons against MPP + neurotoxicity via CD47-SIRPA interaction. Cell Physiol Biochem 41(3):1240–1254. https://doi.org/10.1159/000464388

Article  CAS  PubMed  Google Scholar 

Kachler K, Holzinger C, Trufa DI, Sirbu H, Finotto S (2018) The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma. OncoImmunology. https://doi.org/10.1080/2162402X.2018.1456612

Article  PubMed  PubMed Central  Google Scholar 

Karaaslan Z, Kahraman ÖT, Şanlı E, Ergen HA, Ulusoy C, Bilgiç B, Yılmaz V, Tüzün E, Hanağası HA, Küçükali Cİ (2021) Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson’s disease patients. Sci Reports. https://doi.org/10.1038/s41598-021-81961-7

Article  Google Scholar 

Kiyici M, Nak SG, Budak F, Gurel S, Oral B, Dolar E, Gulten M (2006) Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection. J Gastroenterol Hepatol (australia) 21(6):963–969. https://doi.org/10.1111/j.1440-1746.2006.04229.x

Article  Google Scholar 

Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M (2016) Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson’s disease. Sci Rep 6(September):1–17. https://doi.org/10.1038/srep33738

Article  CAS  Google Scholar 

Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, Sturchio A, Mauri M, Bono G, Marino F, Cosentino M (2018) Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/Th17 and Treg in drug-naïve and drug-treated patients. J Neuroinflammation 15(1):1–17. https://doi.org/10.1186/s12974-018-1248-8

Article  CAS  Google Scholar 

Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, Zhang X, Deng H, Jankovic J (2008) Decreased NURR1 gene expression in patients with Parkinson’s disease. J Neurol Sci 273(1–2):29–33. https://doi.org/10.1016/j.jns.2008.06.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levine AG, Medoza A, Hemmers S, Moltedo B, Niec RE, Schizas M, Hoyos BE, Putintseva EV, Chaudhry A, Dikiy S, Fujisawa S, Chudakov DM, Treuting PM, Rudensky AY (2017) Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546(7658):421–425. https://doi.org/10.1038/nature22360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Yang Z, Li S, Cheng C, Shen B, Le W (2018) Alterations of NURR1 and cytokines in the peripheral blood mononuclear cells: combined biomarkers for Parkinson’s disease. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2018.00392

Article  PubMed  PubMed Central  Google Scholar 

Li W, Luo Y, Xu H, Ma Q, Yao Q (2021) Imbalance between T helper 1 and regulatory T cells plays a detrimental role in experimental Parkinson’s disease in mice. J Int Med Res. https://doi.org/10.1177/0300060521998471

Article  PubMed  PubMed Central  Google Scholar 

Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G (2020) Neurodegeneration and inflammation—an interesting interplay in parkinson’s disease. Int J Mol Sci 21(22):1–15. https://doi.org/10.3390/ijms21228421

Article  CAS  Google Scholar 

Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S (2009) Functional delineation and differentiation dynamics of human CD4+ T Cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911. https://doi.org/10.1016/j.immuni.2009.03.019

Article  CAS  PubMed  Google Scholar 

Olde-Dubbelink KTE, Schoonheim MM, Deijen JB, Twisk JWR, Barkhof F, Berendse HW (2014) Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology 83(22):2046–2053. https://doi.org/10.1212/WNL.0000000000001020?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub

Article  CAS  PubMed  Google Scholar 

Olsen I, Sollid LM (2013) Pitfalls in determining the cytokine profile of human T cells. J Immunol Methods 390(1–2):106–112. https://doi.org/10.1016/j.jim.2013.01.015

Article  CAS  PubMed  Google Scholar 

Pajares M, Rojo A, Manda G, Boscá L, Cuadrado A (2020) Inflammation in Parkinson’s disease: mechanisms and therapeutic implications. Cells. https://doi.org/10.3390/cells9071687

Article  PubMed  PubMed Central  Google Scholar 

Peralta Ramos JM, Iribarren P, Bousset L, Melki R, Baekelandt V, Van der Perren A (2019) Peripheral inflammation regulates CNS immune surveillance through the recruitment of inflammatory monocytes upon systemic α-synuclein administration. Front Immunol. https://doi.org/10.3389/fimmu.2019.00080

Article